- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07232056
Geriatrische Oncologie Beoordeling en Copingvaardigheidstraining voor Oudere Vrouwen op Aromataseremmer Therapie (GOAL-AI)
Geriatrische Oncologie Beoordeling om te Koppelen met Ondersteuning voor Oudere Vrouwen die Adjuvante Aromatase Remmer Therapie Gebruiken
Older women (≥65 years) with HR+ non-metastatic breast cancer experience high symptom burden and reduced quality of life during aromatase inhibitor (AI) therapy. This hierarchical 2×2 factorial randomized controlled trial will test two interventions: (1) a clinic-level geriatric oncology assessment and support program (GOAL-AI) and (2) a patient-level CBT-based coping skills training (CST-AI). The study aims to improve pain, symptom burden, and health-related quality of life compared to enhanced usual care.
Studie Overzicht
Toestand
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Smrithi Divakaran, MBBS, MSPH
- Telefoonnummer: 919-681-7695
- E-mail: smrithi.divakaran@duke.edu
Studie Contact Back-up
- Naam: Michael W Willis, BA
- Telefoonnummer: 919-681-8437
- E-mail: michael.w.willis@duke.edu
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Female, age ≥65 years
- HR+ non-metastatic breast cancer
- Within 12 months of starting AI therapy
- English-speaking
- Able to provide consent
Exclusion Criteria:
- Age <65 years
- Metastatic cancer
- Cognitive impairment preventing consent
- Receiving care at multiple participating sites
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Faculteitstoewijzing
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: GOAL-AI + CST-AI
Combination of clinic-level geriatric assessment and CBT-based coping skills training. |
Clinic-level geriatric assessment and support program. CBT-based coping skills training via telehealth. |
|
Experimenteel: GOAL-AI alone
Clinic-level geriatric assessment and support only. |
Clinic-level geriatric assessment and support program. |
|
Experimenteel: CST-AI alone
CBT-based coping skills training only. |
CBT-based coping skills training via telehealth. |
|
Geen tussenkomst: Enhanced Usual Care
Standard care with educational materials. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in pain severity and interference as measured by the Brief Pain Inventory - Short Form
Tijdsspanne: Baseline, 6 months, 12 months
|
The Brief Pain Inventory-Short Form (BPI-SF) will be used to assess pain severity and interference from pain across important life domains (e.g., general activity, work, relations with others). To calculate a pain severity score, the BPI-SF averages worst, least, average and current pain severity ratings on a 0 to 10 scale, with higher scores indicating more severe pain. To calculate a pain interference score, 7 items asking about interference from pain across different life domains will be averaged, with higher scores indicating higher pain interference. |
Baseline, 6 months, 12 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in emotional distress, as measured by the PROMIS® Anxiety and Depression 4-item Short Forms
Tijdsspanne: Baseline, 6 months, 12 months
|
For the PROMIS® Anxiety and Depression 4-item Short Forms (4a, v1.0) items are summed to create a raw score from 4 to 20 that is converted to a T-score. Responses are on a 5-point scale from "never" (1) to "always" (5). Higher scores indicate higher emotional distress. |
Baseline, 6 months, 12 months
|
|
Change in fatigue, as measured by the PROMIS® Fatigue 6-item Short Form
Tijdsspanne: Baseline, 6 months, 12 months
|
For the PROMIS® Fatigue 6-item Short Form (6a, v1.0) items are summed to create a raw score that is converted to a T-score. Participants are asked to think about the last week when responding to each item (e.g., "In the past 7 days, how run-down did you feel, on average?"), providing ratings on a scale from "not at all" (1) to "very much" (5). Sum scores may range from 6 to 30, with higher scores indicating higher fatigue. |
Baseline, 6 months, 12 months
|
|
Change in physical function, as measured by the Five Times Sit to Stand Test (5xSST)
Tijdsspanne: Baseline, 6 months, 12 months
|
The Five Times Sit to Stand Test (5xSST) assesses functional lower extremity strength, balance, risk of fall, functional decline, and frailty. The amount of time it takes a patient to sit and stand five times in succession with arms folded across their chest is averaged across three trials. |
Baseline, 6 months, 12 months
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Rebecca Shelby, PhD, Duke University
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- Pro00118528
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
The following data will be preserved and shared: patient-reported data from study assessments, healthcare utilization data collected from the health record, AI adherence data collected via self-report and from the health record, physical function and geriatric assessment data collected by study staff in clinic and from the health record, and socio-demographic and medical data collected via patient report and health record.
IPD-tijdsbestek voor delen
Data will be shared either at the time of publication or at the end of the performance period, whichever comes first. All data deposited with the Duke Research Data Repository will be retained for a minimum of 25 years according to their stated Retention Policy.
IPD delen Ondersteunend informatietype
- LEERPROTOCOOL
- SAP
- ICF
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .